Dr. Reddy's Laboratories Limited (DRREDDY.NS)
INR 1109.5
(1.41%)
INR 1109.5
(1.41%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 67.72 Billion INR | 11.18% |
| 2022 | 57.14 Billion INR | 93.87% |
| 2021 | 29.47 Billion INR | 12.54% |
| 2020 | 26.19 Billion INR | 63.77% |
| 2019 | 15.99 Billion INR | -23.43% |
| 2018 | 20.88 Billion INR | 75.28% |
| 2017 | 11.91 Billion INR | -11.71% |
| 2016 | 13.49 Billion INR | -54.43% |
| 2015 | 29.61 Billion INR | 12.68% |
| 2014 | 26.28 Billion INR | 0.98% |
| 2013 | 26.03 Billion INR | 23.3% |
| 2012 | 21.11 Billion INR | 15.67% |
| 2011 | 18.25 Billion INR | 44.54% |
| 2010 | 12.62 Billion INR | 528.88% |
| 2009 | 2 Billion INR | 170.85% |
| 2008 | -2.83 Billion INR | -184.4% |
| 2007 | 3.35 Billion INR | -70.16% |
| 2006 | 11.25 Billion INR | 678.25% |
| 2005 | 1.44 Billion INR | 494.5% |
| 2004 | -366.46 Million INR | -117.58% |
| 2003 | 2.08 Billion INR | -37.52% |
| 2002 | 3.33 Billion INR | -34.06% |
| 2001 | 5.06 Billion INR | 240.61% |
| 2000 | 1.48 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 17.54 Billion INR | 24.15% |
| 2024 Q2 | 16.58 Billion INR | 0.05% |
| 2023 Q4 | 14.13 Billion INR | -18.17% |
| 2023 Q2 | 17.86 Billion INR | 1.31% |
| 2023 Q1 | 17.63 Billion INR | 42.46% |
| 2023 Q3 | 17.26 Billion INR | -3.36% |
| 2023 FY | 63.53 Billion INR | 11.18% |
| 2022 Q1 | 12.21 Billion INR | 703.95% |
| 2022 FY | 57.14 Billion INR | 93.87% |
| 2022 Q4 | 12.38 Billion INR | -24.63% |
| 2022 Q3 | 16.42 Billion INR | 1.85% |
| 2022 Q2 | 16.12 Billion INR | 32.06% |
| 2021 Q1 | 6.6 Billion INR | -12.77% |
| 2021 Q2 | 12.11 Billion INR | 83.37% |
| 2021 FY | 29.47 Billion INR | 12.54% |
| 2021 Q3 | 9.23 Billion INR | -23.77% |
| 2021 Q4 | 1.51 Billion INR | -83.55% |
| 2020 Q2 | 8.31 Billion INR | 2.52% |
| 2020 Q4 | 7.57 Billion INR | 244.43% |
| 2020 FY | 26.19 Billion INR | 63.77% |
| 2020 Q3 | 2.19 Billion INR | -73.54% |
| 2020 Q1 | 8.1 Billion INR | 22.8% |
| 2019 Q4 | 6.6 Billion INR | 212.49% |
| 2019 FY | 15.99 Billion INR | -23.43% |
| 2019 Q3 | -5.86 Billion INR | -180.22% |
| 2019 Q1 | 7.94 Billion INR | 48.62% |
| 2019 Q2 | 7.31 Billion INR | -7.91% |
| 2018 Q4 | 5.34 Billion INR | -6.7% |
| 2018 FY | 20.88 Billion INR | 75.28% |
| 2018 Q1 | 4.76 Billion INR | 80.13% |
| 2018 Q2 | 5.04 Billion INR | 5.83% |
| 2018 Q3 | 5.72 Billion INR | 13.54% |
| 2017 FY | 11.91 Billion INR | -11.71% |
| 2017 Q4 | 2.64 Billion INR | -47.16% |
| 2017 Q3 | 5 Billion INR | 31.54% |
| 2017 Q2 | 3.8 Billion INR | 740.62% |
| 2017 Q1 | 453 Million INR | -85.55% |
| 2016 Q3 | 5.78 Billion INR | 70.97% |
| 2016 Q2 | 3.38 Billion INR | 185.02% |
| 2016 FY | 13.49 Billion INR | -54.43% |
| 2016 Q1 | 1.18 Billion INR | -76.58% |
| 2016 Q4 | 3.13 Billion INR | -45.85% |
| 2015 Q3 | 7.57 Billion INR | -18.14% |
| 2015 Q4 | 5.07 Billion INR | -33.07% |
| 2015 Q1 | 7.71 Billion INR | 26.01% |
| 2015 Q2 | 9.25 Billion INR | 20.03% |
| 2015 FY | 29.61 Billion INR | 12.68% |
| 2014 Q1 | 6.47 Billion INR | 10.55% |
| 2014 FY | 26.28 Billion INR | 0.98% |
| 2014 Q4 | 6.12 Billion INR | -15.31% |
| 2014 Q3 | 7.22 Billion INR | 11.77% |
| 2014 Q2 | 6.46 Billion INR | -0.15% |
| 2013 FY | 26.03 Billion INR | 23.3% |
| 2013 Q3 | 8.64 Billion INR | 17.45% |
| 2013 Q2 | 7.36 Billion INR | 76.46% |
| 2013 Q1 | 4.17 Billion INR | -43.84% |
| 2013 Q4 | 5.85 Billion INR | -32.24% |
| 2012 Q1 | 3.91 Billion INR | -6.07% |
| 2012 Q2 | 5.24 Billion INR | 33.79% |
| 2012 Q3 | 4.72 Billion INR | -9.81% |
| 2012 Q4 | 7.42 Billion INR | 57.09% |
| 2012 FY | 21.11 Billion INR | 15.67% |
| 2011 Q1 | 2.78 Billion INR | -27.43% |
| 2011 FY | 18.25 Billion INR | 44.54% |
| 2011 Q2 | 3.74 Billion INR | 34.28% |
| 2011 Q3 | 7.54 Billion INR | 101.52% |
| 2011 Q4 | 4.17 Billion INR | -44.73% |
| 2010 FY | 12.62 Billion INR | 528.88% |
| 2010 Q4 | 3.84 Billion INR | 31.03% |
| 2010 Q3 | 2.93 Billion INR | -9.11% |
| 2010 Q2 | 3.22 Billion INR | 22.93% |
| 2010 Q1 | 2.62 Billion INR | 24.35% |
| 2009 Q1 | 3.29 Billion INR | 134.8% |
| 2009 FY | 2 Billion INR | 170.85% |
| 2009 Q4 | 2.11 Billion INR | 135.5% |
| 2009 Q3 | -5.94 Billion INR | -333.73% |
| 2009 Q2 | 2.54 Billion INR | -22.79% |
| 2008 Q3 | 3.75 Billion INR | 112.57% |
| 2008 Q4 | -9.46 Billion INR | -352.3% |
| 2008 Q2 | 1.76 Billion INR | 10.48% |
| 2008 Q1 | 1.59 Billion INR | 27.35% |
| 2008 FY | -2.83 Billion INR | -184.4% |
| 2007 Q1 | 2.06 Billion INR | -39.78% |
| 2007 Q4 | 1.25 Billion INR | 198.62% |
| 2007 Q3 | -1.27 Billion INR | -175.6% |
| 2007 Q2 | 1.68 Billion INR | -18.66% |
| 2007 FY | 3.35 Billion INR | -70.16% |
| 2006 Q2 | 3.86 Billion INR | 112.06% |
| 2006 Q1 | 1.82 Billion INR | 811.28% |
| 2006 FY | 11.25 Billion INR | 678.25% |
| 2006 Q4 | 3.43 Billion INR | 62.77% |
| 2006 Q3 | 2.11 Billion INR | -45.33% |
| 2005 Q2 | 692.18 Million INR | 136.84% |
| 2005 Q1 | 292.26 Million INR | 138.68% |
| 2005 Q4 | -255.92 Million INR | -134.25% |
| 2005 Q3 | 747.17 Million INR | 7.94% |
| 2005 FY | 1.44 Billion INR | 494.5% |
| 2004 Q3 | -89.3 Million INR | -118.79% |
| 2004 Q4 | -755.59 Million INR | -746.09% |
| 2004 Q2 | 475.22 Million INR | 984.6% |
| 2004 Q1 | 43.81 Million INR | 114.86% |
| 2004 FY | -366.46 Million INR | -117.58% |
| 2003 Q4 | -294.95 Million INR | -151.29% |
| 2003 FY | 2.08 Billion INR | -37.52% |
| 2003 Q1 | 846.04 Million INR | 53.25% |
| 2003 Q2 | 964.71 Million INR | 14.03% |
| 2003 Q3 | 575.06 Million INR | -40.39% |
| 2002 Q2 | 926.37 Million INR | -24.88% |
| 2002 FY | 3.33 Billion INR | -34.06% |
| 2002 Q4 | 552.08 Million INR | -12.24% |
| 2002 Q3 | 629.11 Million INR | -32.09% |
| 2002 Q1 | 1.23 Billion INR | 47.28% |
| 2001 Q1 | 516.68 Million INR | 0.0% |
| 2001 FY | 5.06 Billion INR | 240.61% |
| 2001 Q4 | 837.26 Million INR | -43.66% |
| 2001 Q3 | 1.48 Billion INR | -33.11% |
| 2001 Q2 | 2.22 Billion INR | 329.98% |
| 2000 FY | 1.48 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -1076.239% |
| Hester Biosciences Limited | 364.77 Million INR | -18467.591% |
| Aarti Drugs Limited | 7.14 Billion INR | -847.428% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -2065.169% |
| Albert David Limited | 1.33 Billion INR | -4975.398% |
| Alembic Limited | 767.77 Million INR | -8721.522% |
| Alkem Laboratories Limited | 19.46 Billion INR | -248.008% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -28398.155% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -327790.201% |
| Brooks Laboratories Limited | -72.25 Million INR | 93839.966% |
| Eris Lifesciences Limited | 5.18 Billion INR | -1207.076% |
| FDC Limited | 3.03 Billion INR | -2132.525% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -654.289% |
| Gufic Biosciences Limited | 2.89 Billion INR | -2240.483% |
| Hikal Limited | 1.49 Billion INR | -4432.793% |
| Ind-Swift Limited | 1.22 Billion INR | -5424.55% |
| Innova Captab Limited | 2.53 Billion INR | -2573.432% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -1270.422% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -31543.151% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -1205.242% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -3452.851% |
| Lupin Limited | 27.75 Billion INR | -143.997% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -246563.996% |
| Medico Remedies Limited | 277.11 Million INR | -24340.491% |
| Morepen Laboratories Limited | 4.17 Billion INR | -1522.706% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -1640.841% |
| Orchid Pharma Limited | 2.36 Billion INR | -2768.563% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -2331.048% |
| RPG Life Sciences Limited | 2.29 Billion INR | -2854.631% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -32454.194% |
| Sigachi Industries Limited | 1.47 Billion INR | -4495.236% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 1857.871% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -1369.927% |
| Themis Medicare Limited | 1.3 Billion INR | -5097.509% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -1075988.338% |
| Wanbury Limited | 1.7 Billion INR | -3867.24% |
| Windlas Biotech Limited | 1.29 Billion INR | -5114.375% |
| ZIM Laboratories Limited | 1.09 Billion INR | -6067.762% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -3271.224% |
| Ipca Laboratories Limited | 29.59 Billion INR | -128.841% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 35.066% |
| Venus Remedies Limited | 534.65 Million INR | -12567.89% |
| Sakar Healthcare Limited | 495.5 Million INR | -13568.654% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 35.19% |
| Divi's Laboratories Limited | 18.31 Billion INR | -269.902% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -1413.869% |
| Mankind Pharma Limited | 40.86 Billion INR | -65.728% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Laurus Labs Limited | 3.94 Billion INR | -1615.266% |
| Neuland Laboratories Limited | 5.31 Billion INR | -1173.558% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | -798.067% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -941.603% |
| Zydus Lifesciences Limited | 45.39 Billion INR | -49.209% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -10805.967% |
| Wockhardt Limited | 140 Million INR | -48277.857% |
| Bal Pharma Limited | 214.56 Million INR | -31465.138% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -5401.945% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -12178.889% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | -837.387% |
| Shilpa Medicare Limited | 3.76 Billion INR | -1700.55% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | -244.199% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -2392452.562% |
| Granules India Limited | 6.52 Billion INR | -937.474% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -27073.01% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | -167.332% |
| NATCO Pharma Limited | 25.96 Billion INR | -160.877% |
| Suven Life Sciences Limited | -1.22 Billion INR | 5625.19% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -1196.048% |
| Indoco Remedies Limited | 1.52 Billion INR | -4342.994% |
| Alpa Laboratories Limited | 61.51 Million INR | -110001.601% |
| Lasa Supergenerics Limited | -458 Million INR | 14887.83% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 1745.889% |